دورية أكاديمية

Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate.

التفاصيل البيبلوغرافية
العنوان: Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate.
المؤلفون: Ghafari-Saravi A; Department of Dermatology, Oregon Health and Science University, Portland, OR., Foster E
المصدر: Journal of lower genital tract disease [J Low Genit Tract Dis] 2024 Apr 01; Vol. 28 (2), pp. 202-204. Date of Electronic Publication: 2024 Jan 10.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9704963 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-0976 (Electronic) Linking ISSN: 10892591 NLM ISO Abbreviation: J Low Genit Tract Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: 2002- : Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Malden, MA : Blackwell Science Inc., c1997-
مواضيع طبية MeSH: Lichen Sclerosus et Atrophicus*/drug therapy , Vulvar Lichen Sclerosus*/drug therapy, Adult ; Female ; Humans ; Administration, Topical ; Glucocorticoids/therapeutic use ; Methotrexate/therapeutic use
مستخلص: We report the successful treatment of severe vulvar lichen sclerosus refractory to topical corticosteroids in 3 adult female patients using low-dose oral methotrexate. All cases reported symptomatic and clinical improvement within 12 weeks.
Competing Interests: The authors have declared they have no conflicts of interest.
(Copyright © 2024, ASCCP.)
References: Akel R, Fuller C. Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol . 2018;178:823.
Wehbe-Alamah H, Kornblau BL, Haderer J, et al. Silent no more! The lived experiences of women with lichen sclerosis. J Am Acad Nurse Pract 2012;24:499–505.
Tran DA, Tan X, Macri CJ, et al. Lichen sclerosus: an autoimmunopathogenic and genomic enigma with emerging genetic and immune targets. Int J Biol Sci 2019;15:1429–39.
Roenigk HH, Auerbach R, Maibach H, et al. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol 1998;38:478–85.
Kroft E, Creemers M, Van Den Hoogen F, et al. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study. Br J Dermatol . 2009;160:1075–82.
Weatherhead S, Wahie S, Reynolds N, et al. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol 2007;156:346–51.
Lundqvist EN, Wahlin YB, Hofer P-A. Methotrexate supplemented with steroid ointments for the treatment of severe erosive lichen ruber. Acta Derm Venereol 2002;82:63–4.
Jang N, Fischer G. Treatment of erosive vulvovaginal lichen planus with methotrexate. Australas J Dermatol 2008;49:216.
Kreuter A, Tigges C, Gaifullina R, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus. Arch Dermatol 2009;145:1303–8.
Cuellar-Barboza A, Bashyam AM, Ghamrawi RI, et al. Methotrexate for the treatment of recalcitrant genital and extragenital lichen sclerosus: a retrospective series. Dermatol Ther 2020;33:e13473.
Maździarz A, Osuch B, Kowalska M, et al. Photodynamic therapy in the treatment of vulvar lichen sclerosus. Photodiagnosis Photodyn Ther 2017;19:135–9.
Warren R, Weatherhead S, Smith C, et al. British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. Br J Dermatol . 2016;175:23–44.
المشرفين على المادة: 0 (Glucocorticoids)
YL5FZ2Y5U1 (Methotrexate)
تواريخ الأحداث: Date Created: 20240322 Date Completed: 20240325 Latest Revision: 20240408
رمز التحديث: 20240409
DOI: 10.1097/LGT.0000000000000795
PMID: 38518219
قاعدة البيانات: MEDLINE
الوصف
تدمد:1526-0976
DOI:10.1097/LGT.0000000000000795